chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I recieved my vaccine shot at about 4:20 pm, 1-3 minutes immediately after recieving the shot, I fainted and fell flat onto my face. I was unconcious for about 5-6. After regaining conciousness I immediately had trouble breathing. Paramedics were called to the scene. I lacerated the left side of my face when I fell; and cut and bruised my face also. I had to have 5 stitches for the wound to my face.
feels like she is having a anxiety attack; belching after she eats; chest is heavy; Nausea; Rapid heart beat; chest is heavy was reported as worsened; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 69-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/Lot Number: EL9262), via an unspecified route of administration, administered in arm left on 13Feb2021 at 13:13 (at the age of 69-year-old) as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Concomitant Medications: Patient is on medication but has never had this before. Patient is used to getting vaccines and has never had a problem with a vaccine. The patient did not receive any other vaccines within 4 weeks prior vaccinations. The patient experienced chest is heavy was reported as worsened on an unspecified date in Feb2021; nausea, rapid heartbeat on 14Feb2021; chest is heavy on 17Feb2021; feels like she is having an anxiety attack, belching after she eats on 20Feb2021. The patient did not result in emergency room and physician office visit, but she did call the office. The patient is a consumer that was calling about the Covid-19 vaccine and she reported that she had the first shot on 13Feb2021. Patient said felt fine the whole day, but the next day she a lot of nausea and rapid heartbeat. Patient said that it is like 8 days in, and she still has rapid heartbeat. Patient said that her chest is heavy and she feels like she is having a anxiety attack. Patient called the doctor's office and thought she needed an EKG, she is afraid she is going to have a heart attack. They told her to call Pfizer and then to follow up with them on Wednesday 24Feb2021. Patient said that she wanted to know if she is safe to get the second shot or is it contraindicated. Patient thinks she had Covid in Dec2020, but 3 Covid tests all came back negative. Patient had 3 family members that tested positive when she was sick. Nausea: Patient said that her appetite is kind of screwed up, but has belching after she eats, but is not really nauseous now. Rapid Heartbeat: Patient noticed the rapid heartbeat when she laid down at night, but does not notice that as much now, but she has it all day long and said that it is like a heavy heart. Chest Heaviness: Patient said that she noticed the chest heaviness on Wednesday 17Feb2021. Patient thought at first it was just shallow breathing. Patient 2nd shot is scheduled for 06Mar2021. The patient underwent lab tests and procedures which included COVID tests was negative (3 Covid tests all came back negative). Outcome of the events rapid heartbeat, chest is heavy, feels like she is having a anxiety attack, belching after she eats was not recovered; chest is heavy was reported as worsened was unknown; nausea was recovered on 20Feb2021.  Follow-Up (PRD/SRD 03Apr2021): Follow-up attempts are completed. No further information is expected.
Headache, Myalgia, fever, night sweats Narrative: Symptoms started on 1/16/21 the next day chills for most of the day, body aches, increased back pain, ha that went from front of head to back and base of neck. On Sun 1/17/21 had same symptoms and then night sweats. 1/18/21 body aches were starting to go away, still had night sweats and by 1/19/21 employee reported feeling much better with no signs and symptoms. She never had a reaction like this from a vaccine.
This spontaneous report as received from a other health professional refers to a patient of unknown age. On 16-MAY-2017 the patient was vaccinated with ROTATEQ lot # M040268 for prophylaxis. On 16-MAY-2017, 1 day after onset of therapy the patient experienced incorrect product storage. On an unknown date the patient experienced no adverse event. The outcome of incorrect product storage and no adverse event is unknown. The reporter considered incorrect product storage and no adverse event to be not related to ROTATEQ.; Sender's Comments: US-009507513-1708USA003628: US-009507513-1708USA003629: US-009507513-1708USA003635: US-009507513-1708USA003631: US-009507513-1708USA003632: US-009507513-1708USA003633: US-009507513-1708USA003634: US-009507513-1708USA003627: US-009507513-1708USA011937: US-009507513-1709USA001553: US-009507513-1708USA003630: US-009507513-1709USA001554:
09/8/06 at 6am awoke to rash on bilateral hand, progressed overtime spreading to wrist, back and then to bilateral feet. Seen by MD on 9/28/06 DX with allergic reaction to Hep A vaccine TX given Cloderm,  Clobetasol
With the intention of planting an intradermal PPD (testing for Tuberculosis), 0.1ml IPV was used instead of 0.1ml of tubersol. Patient notified of mistake, as was program director.
she woke up with "covid arm"; she also had hives all over her body; feeling itchy; a big rash at the injection site that it's getting better; body ache; Nausea; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body ache), PAIN IN EXTREMITY (she woke up with "covid arm"), URTICARIA (she also had hives all over her body), PRURITUS (feeling itchy) and NAUSEA (Nausea) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy, Peanut allergy, Fruit allergy (fresh fruit.) and Allergy to nuts (tree nut.).    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced PAIN (body ache), NAUSEA (Nausea) and FATIGUE (Fatigue). On 20-Mar-2021, the patient experienced PAIN IN EXTREMITY (she woke up with "covid arm"), URTICARIA (she also had hives all over her body), PRURITUS (feeling itchy) and RASH (a big rash at the injection site that it's getting better). On 15-Mar-2021, PAIN (body ache) outcome was unknown, NAUSEA (Nausea) and FATIGUE (Fatigue) had resolved. At the time of the report, PAIN IN EXTREMITY (she woke up with "covid arm") had resolved and URTICARIA (she also had hives all over her body), PRURITUS (feeling itchy) and RASH (a big rash at the injection site that it's getting better) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       treatment include topical Benadryl. No other medication reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-119837 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: the follow up were received on 11-MAY-2021 , the patient details were updated, relevant history was updated , event outcome updated; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-119837:First dose case
This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (has gotten a full third dose after the first trimester of second pregnancy) in a 31-year-old female patient (gravida 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included Pregnancy (At 18 weeks pregnant, the baby had to be medically aborted). Concurrent medical conditions included Pregnancy (now past 18 weeks of pregnancy). On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 10-May-2022. On an unknown date, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (has gotten a full third dose after the first trimester of second pregnancy). At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (has gotten a full third dose after the first trimester of second pregnancy) had resolved. Not Provided. The patient was previously pregnant when first dose was taken, which resulted in medical abortion at 18 weeks pregnancy. The patient went in for anatomical study late Aug-2021 and the next day, had the medical abortion. A week before everything was fine. The daughter had a different ultrasound a week prior and everything was fine. It happened suddenly that the baby's brain was surrounded in fluid and baby was brain dead. The patient went in for the study and baby was surrounded in fluid. The fetus had a chamber at base of neck that didn't close. Baby's due date was mid Nov-2021. The patient now has gotten a full third dose after the first trimester of second pregnancy and experienced depression after abortion but was now doing okay. The patient is now on an unspecified antidepressant and undergoing psychotherapy. This case was linked to MOD-2021-042890 (Patient Link).
Loss of apatite to the point of no ingestion through mouth. During hospitalization, the medical staff identified a mass at the abdomen.
12 month old female patient was inadvertently administered GARDASIL 9 instead ofVAQTA; 12 month old female patient was inadvertently administered GARDASIL 9 instead ofVAQTA; the patient has not had any residual side effects from receiving the GARDASIL 9; This spontaneous report was received from a registered nurse concerning a 12-month-old female patient. There was no information about the patient's medical history, concurrent conditions or concomitant medication.  On 12-NOV-2020, the patient was inadvertently administered vaccinated with a dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9), prefilled syringe,  lot # S031287 expiration date not reported, but upon internal validation established as 08-APR-2022(dose, and route of administration, were not reported instead of hepatitis a vaccine, inactivated(VAQTA) (dose, route of administration, lot number and expiration date were not reported). prophylaxis. The nurse stated that she was not sure how this error occurred. The nurse mentioned currently, the patient had not had any residual side effects from receiving the hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) in error. No additional adverse events. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.  devicelotnumber: S031287; expirationdate: 08-APR-2022; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
Patient received vaccine and had severe soreness that night after getting the shot. The arm felt like it was radiating heat and there was some swelling. The patient came into the pharmacy the next day and her arm still had swelling on the lower part of her left arm around her bicep and tricep area and the patient states that it is still radiating heat.
On 01/08/2002, at the clinic, the pt was given an MMR with her mother present. The time was approx 3:45pm. While the nurse was signing the dates on the mother's immunization records, the pt got up from the chair and walked over to the corner area of the desk near the doorway. After a noise was heard, we saw that the pt has fallen and was lying unconscious with her head in the corner area. Her color was very paleand she had circumoral cyanosis. We moved her out a small ways so that she would be laying on her back away from the desk. She then went into a seizure and wet her pants.At the time we called out to call 911 for an ambulance. The mother stated that she had had the MMR before and had never had a seizure. After the seizure, she became conscious and could answer questions about any pain. She nodded that her head hurt and put her hand on her head. A bluish colored knot was found and her right forehead near the temporal region. Her blood pressure was checked and was 102/54. The ambulance arrived shortly and waited until the mother could reach her husband by the phone so that he could meet the family at the hospital. Later she appeared much better as she was taken to the ambulance by stretcher. On 01/09/2002, the nurse called the mother to inquire about the pt's condition. She stated that ER checked her and had a Cat Scan and x-ray taken. All tests were normal except for finding that she had a bladder infection and was given Bactrim. The pt was fine the rest of the evening and night, except for a small headache, and was ready for school the next morning. The mother alerted the school to be aware of the situation.
high pitched screaming & crying x 3 hrs; react to vax still fussy 21MAR95 giving APAP today also;
Vaccinated pt overnight in ED with covid infection. No information available on place, time, date, or any other info on vaccination. Self reported vaccination status.
pt. recd vax & within 1 mnth developed a rash & pharyngitis.
COVID Arm, large red knot on right arm hot to the touch. Nausea and 100.4 fever for 24 hours. COVID Arm has been present for 3 days so far, but starting to go away
Red and sore arm from injection area down to mid lower arm area for 2 days, then patient developed all over aches and some nausea for 2 more days bad enough to stay in bed mostly.
Fainted going to check out, didn't wait after vaccination; This is a spontaneous report received from contactable reporter(s) (Other HCP) from a sales representative.  A 16-year-old male patient received meningococcal group b Rlp2086 (TRUMENBA), as dose number unknown, single (Lot number: FN5547, Expiration Date: 31Jul2025) at the age of 16 years for immunisation. The patient had no relevant medical history. Concomitant medication(s) included: MENQUADFI taken for immunisation. The following information was reported: SYNCOPE (medically significant), outcome "unknown", described as "Fainted going to check out, didn't wait after vaccination". The patient underwent the following laboratory tests and procedures: Body height: 204, notes: unit unknown.; Sender's Comments: There is a reasonable possibility that the event syncope was related to TRUMENBA based on known drug safety profile.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
pt was crying, given vax & fainted in mom's arm;observed momentary stiffening of extremities;last approx 2-3sec;awoke & resumed crying;cont crying referred to PMD mom states crying episode lasting 45min;sl febrile 100 in PM;APAP given;n/v;
Information has been received from a registered nurse concerning an otherwise healthy 6 year old Caucasian female with no allergies who on 6/16/95 was vaccinated with one dose of varicella virus vaccine live SC. On 5/17/97, the patient developed lesions all over her body. The reporter noted that causality is unknown. Additional information has been requested.
This case was reported by a nurse via sales rep and described the occurrence of fainting in a 18-year-old female patient who received BEXSERO (batch number 16G201, expiry date May 2019) for prophylaxis. On 26th July 2018, the patient received BEXSERO. On 26th July 2018, less than a day after receiving BEXSERO, the patient experienced fainting. On an unknown date, the outcome of the fainting was unknown. It was unknown if the reporter considered the fainting to be related to BEXSERO. Additional details were reported as follows: The patient received BEXSERO in left deltoid. After receiving BEXSERO the patient felt ok. At the checkout desk the patient fainted. The patient did not have anything to eat yet. This was at 10 AM. The patient was basically rolled out of bed and came to office for the vaccine.
Per, a female pregnant patient at 29 weeks of pregnancy was inadvertently administered GARDASIL-9 instead of TDAP.; Per, a female pregnant patient at 29 weeks of pregnancy was inadvertently administered GARDASIL-9 instead of TDAP.; No additional AE; This spontaneous report was received from an office manager and refers to a pregnant female patient of unknown age. The patient's medical history, concurrent conditions, and concomitant therapies were not reported.  On an unspecified date, the patient was vaccinated with human papillomavirus (HPV) rl1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) injection, administered for prophylaxis (dose, frequency, strength, lot #, expiry date, anatomical location, and route of administration were not provided) instead of diphtheria vaccine toxoid (+) pertussis vaccine acellular (+) tetanus vaccine toxoid (TDAP) (Wrong product administered). At this time, she was at 29 weeks of pregnancy (Exposure during pregnancy). She sought medical attention. No additional information or adverse event was reported (No adverse event).
Destruction of memory recall. Specifically, the following happened. In the summer of 2020, I received a stem cell injection. I had a wonderful, positive reaction. My memory recall prior to the injection had been poor, and I struggled to recall information that I knew was committed to memory. After the stem cell injection, all limitations to memory recall were gone, and I could recall all memories I had. No barriers. I was thrilled. But after receiving the second Moderna injection, that ability was wiped out. It is as if I never had the stem cell injection. Now I struggle to recall memories, as I did before the stem cell injection. The second Moderna injection has erased the benefit of the stem cell injection and injured my brain. I am devastated. And this cannot be reversed, as the FDA has halted stem cell injections in this country. I cannot get another one to undo the damage of the COVID vaccine.
Didn't feel good; Coughing a lot; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 59-year-old female patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MALAISE (non-serious), outcome "unknown", described as "Didn't feel good"; COUGH (non-serious), outcome "unknown", described as "Coughing a lot".  Additional information: The patient didn't feel good and laid down. She normally doesn't cough.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
myopericarditis with SOB 2 days after vaccine.  diffuse ST elevation EKG.  troponins 8-20.  echo with mild function decrease.
Pt recv vax on 3/1/99; 1/2 hr post vax pt exp nasal congestion, watery eyes, facial edema, wheezing, urticaria on forearms; tx= Benadryl
large elevated (swollen) round rash on left arm with hardness in middle.  Noticed it day after injection (2/25).  Became itchy on 2/26.  Faint inner circle inside larger rash. Mildly annoying but strange looking. This did not occur after 1st injection on 2/21 Pfizer EL9265.
This case was reported by a consumer via call center representative and described the occurrence of burning sensation in a 66-year-old female patient who received SHINGRIX for prophylaxis. On 1st February 2019, the patient received the 1st dose of SHINGRIX. In February 2019, less than a week after receiving SHINGRIX, the patient experienced burning sensation, erythema and pruritus. On an unknown date, the outcome of the burning sensation, erythema and pruritus were recovering/resolving. It was unknown if the reporter considered the burning sensation, erythema and pruritus to be related to SHINGRIX. Additional details were reported as follows: The patient experienced the listed side effects after dose of SHINGRIX. The patient symptoms were just starting to resolve as of today.
Patient developed a rash that was concentrated on her knees and elbows, and also presented at lower density on her ankles and knees. This rash was first observed by me on Wednesday, February 9th in the evening, and had worsened by Thursday morning and even more by Thursday night. I took her to her pediatrician (Friday 2/11 at 4 pm local time), who said her rash was consistent with Gianotti Crosti syndrome. Patient was prescribed Kenalog (tramcinolone 0.025%, 2x/day) and was also instructed to take Zyrtec.  Her rash is still present and is extremely itchy, although it has not spread further.
The day after I received the vaccine I was extremely tired, had a headache, and my entire body felt sore. The arm that I got the shot in hurt very bad for the next two days and I now have a bruise at the injection site.
Pt complains of pain, burning and swelling, distal to injection site. Seen by doctor. Treated with Keflex 500 mg 4-1-04.
Body and muscular aches in entire body. Slight headache. Extreme fatigue. Symptoms continued  From 1:30 am on 2/26 for approximately 24 hours.
This case was reported by a nurse via call center representative and described the occurrence of chills in a 75-year-old male patient who received SHINGRIX for prophylaxis. Co-suspect products included Flu Seasonal QIV Dresden for prophylaxis and PNEUMOCOCCAL VACCINE for prophylaxis. Concurrent medical conditions included neoplasm malignant. On 29th August 2018, the patient received SHINGRIX (intramuscular), Influenza vaccine Quadrivalent 2017-2018 season and PNEUMOCOCCAL VACCINE. On 29th August 2018, less than a day after receiving SHINGRIX and an unknown time after receiving Influenza vaccine Quadrivalent 2017-2018 season and PNEUMOCOCCAL VACCINE, the patient experienced chills. On an unknown date, the outcome of the chills was recovering/resolving. It was unknown if the reporter considered the chills to be related to SHINGRIX and Influenza vaccine Quadrivalent 2017-2018 season. Additional details were provided as follows: This case was reported by the patient's wife who was also a nurse. The nurse reported that her husband got SHINGRIX, pneumococcal and flu vaccines a day before reporting and in the evening he started experiencing chills, though he did not have a fever.
Started slowly, but progressed overtime to present. DR. prescribed several medication for allergy and Afrin to relieve congestion temporally. The result was congestion relieved, not the breathing problem- negative. I then saw an ENT, Dr.. He treated cough, but said I should see an Allergist. This was because of my breathing problem. At night I cannot fall asleep. I gasp for air and have not had a good nights sleep in months-it's getting worse. I am seeing an Allergist  this coming week. If he cannot help me, then reasonable suspect may be the final injection shot on 03/11/2021. I have a cough that won't quit and heavy breathing at night which keeps me from falling asleep. Before 03/11/2021 I was fine.
This is a spontaneous report received from a contactable reporter(s) (consumer or other non-HCP) from Regulatory Authority sponsored program (159558). The reporter is the patient. A female patient received bnt162b2 (BNT162B2), administration date 05Mar2021 (Batch/Lot number: unknown) as single dose for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "feeling tired". No follow-up attempts are possible. No further information is expected.
pt recv vax & immed devel whole body hives;rx DPH;hives resolved w/in 1hr;no resp distress;pt is not allergic to eggs;